Medindia neither buys nor sells drugs. Capecitabine (Capiibine (500 mg)) is an antimetabolite, prescribed for breast cancer and colorectal cancer. It prevents the growth of cancer cells.

Capecitabine Tablets, 150 & 500 mg, which are indicated for the treatment of metastatic breast cancer, had U.S. sales of approximately $393 million for the 12 months ending December 2016 ...

announces the launch of the generic equivalent to Xeloda® (Capecitabine) Tablets, 150 MG and 500 MG, in the United States. Xeloda® is marketed by Genentech in the United States. Teva was the ...

human epidermal growth factor receptor 2–negative metastatic breast cancer without previous systemic therapy were randomly assigned 1:1 to receive either metronomic capecitabine (500 mg three ...